0001485003-16-000128.txt : 20160707 0001485003-16-000128.hdr.sgml : 20160707 20160707163643 ACCESSION NUMBER: 0001485003-16-000128 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20160707 DATE AS OF CHANGE: 20160707 EFFECTIVENESS DATE: 20160707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161756948 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 DEFA14A 1 ebio_indclearance8-kx15650.htm 8-K Document

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
                                                     

FORM 8-K
 
                                                     
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 7, 2016
 
                                                     

ELEVEN BIOTHERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Charter)
 
                                                     
 
 
 
 
 
 
Delaware
 
001-36296
 
26-2025616
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
 
 
 
215 First Street, Suite 400
Cambridge, MA
 
02142
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (617) 871-9911
None
(Former Name or Former Address, if Changed Since Last Report)
 
                                                     

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 






x  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Item 8.01. Other Events.
 
As previously disclosed in the Current Report on Form 8-K filed on June 13, 2016, by Eleven Biotherapeutics, Inc. (the “Company” or “Eleven”), on June 10, 2016, the Company entered into a License Agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (the “License Agreement”).

On July 7, 2016, the Company issued a press release with respect to the effectiveness of the Company’s Investigational New Drug Application for EBI-031, and the impact of such effectiveness under the License Agreement. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01
Financial Statements and Exhibits.

(d)    Exhibits.
99.1
Press Release, dated July 7, 2016, announcing effectiveness of its Investigational New Drug Application

Important Information

The Company plans to file with the Securities and Exchange Commission (“SEC”) and mail to its stockholders a proxy statement in connection with the transactions contemplated by the License Agreement. Additionally, the Company will file other relevant materials with the SEC in connection with the transactions contemplated by the License Agreement. The proxy statement will contain important information about the Company, the transactions contemplated by the License Agreement and related matters. Investors and security holders are urged to read the proxy statement carefully when it is available before making any voting or investment decision with respect to the proposed transactions because they will contain important information about the proposed transactions.

Investors and security holders will be able to obtain free copies of the proxy statement and other documents filed with the SEC by the Company through the web site maintained by the SEC at www.sec.gov. In addition, investors and security holders will be able to obtain free copies of the proxy statement from public company by contacting Leah Monteiro at (617) 714-0619.

The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the transactions contemplated by the License Agreement. Information regarding the Company’s directors and executive officers is contained in the Company’s Form 10-K for the fiscal year ended December 31, 2015, and its proxy statement dated April 29, 2016, each of which has been filed with the SEC.  Additional information regarding the participants in the solicitation of proxies in respect of the transactions contemplated by the License Agreement and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC when they become available.





Cautionary Note on Forward-Looking Statements

Any statements in this Current Report on Form 8-K about future expectations, plans and prospects for the Company, including statements about the potential effectiveness of the License Agreement or receipt of payments thereunder, the future rights and obligations of the parties under the License Agreement, the Company's strategy, future operations, advancement or maturation of its product candidates and product pipeline, clinical development of the Company's product candidates, including expectations regarding timing of regulatory submissions and initiation of clinical trials, regulatory requirements for initiation of clinical trials and registration of product candidates, the review of its strategic alternatives and the outcome of such review, the completion and results of potential strategic transactions, the sufficiency of its cash resources and other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the occurrence of any event, change or other circumstances that could give rise to the termination of the License Agreement, the outcome of any legal proceedings that could be instituted against the Company or its directors related to the License Agreement, the inability to consummate the transactions contemplated by the License Agreement due to the failure to obtain the requisite approval of the Company’s stockholders, the uncertainties inherent in the initiation and conduct of clinical trials, availability and timing of data from clinical trials, whether results of early clinical trials or preclinical studies will be indicative of the results of future trials, the adequacy of any clinical models, uncertainties associated with regulatory review of clinical trials and applications for marketing approvals and other factors discussed in the "Risk Factors" section of the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission and other reports on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this Current Report on Form 8-K represent the Company's views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.






Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
ELEVEN BIOTHERAPEUTICS, INC.
 
 
 
Date: July 7, 2016
 
By:
 
/s/ Abbie C. Celniker
 
 
 
 
Abbie C. Celniker, Ph.D.
President & Chief Executive Officer






EXHIBIT INDEX


Exhibit Number        Description of Exhibit

99.1
Press Release, dated July 7, 2016, announcing effectiveness of its Investigational New Drug Application











 EX-99.1 2 elevenbio-pressreleaseindc.htm EXHIBIT 99.1 Exhibit


Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031
Eleven entitled to receive $22.5 million milestone payment for IND effectiveness
Cambridge, MA – July 7, 2016 – Eleven Biotherapeutics, Inc. (NASDAQ: EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that the company’s Investigational New Drug (IND) application for EBI-031, a humanized monoclonal antibody that potently binds interleukin-6 (IL-6) and inhibits all known forms of IL-6 cytokine signaling, for treatment of ocular diseases, has become effective. As a result of the achievement of this milestone, Eleven is entitled to receive a $22.5 million payment from F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche) pursuant to the terms of its license agreement with Roche.
On June 13, 2016, Eleven announced that it had entered into an exclusive license agreement with Roche for the further development and commercialization of EBI-031 and all other IL-6 antagonist antibody technology owned by Eleven. Under the terms of the agreement, Eleven could receive up to $262.5 million upon the achievement of certain regulatory, development and commercialization milestones, including this $22.5 million payment upon the effectiveness of the IND for EBI-031. In addition, Eleven could be entitled to receive royalties for net sales of potential future products containing EBI-031 or any other potential future products containing other Eleven IL-6 compounds. Effectiveness of the license agreement, including Roche’s obligation to make the $22.5 million milestone payment, is subject to approval of the license by holders of at least a majority of the outstanding shares of Eleven’s common stock.
“We look forward to Roche advancing EBI-031 into the clinic to explore its potential use for ocular diseases, such as diabetic macular edema, in an effort to bring this potential treatment to patients,” said Abbie Celniker, Ph.D., President and Chief Executive Officer of Eleven Biotherapeutics.
About EBI-031
Eleven Biotherapeutics' most advanced preclinical product candidate is EBI-031 for treatment of diabetic macular edema, or DME, and uveitis. EBI-031 was designed and engineered for intravitreal delivery using Eleven’s AMP-Rx platform. EBI-031 is a potent blocker of both free IL-6 and IL-6 complexed to the soluble IL-6 receptor (IL-6R). Eleven filed an IND with the FDA in June 2016 for the purpose of conducting clinical trials of EBI-031 in DME and uveitis.
About Eleven Biotherapeutics
Eleven Biotherapeutics, Inc. is a preclinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye. Eleven’s therapeutic approach is based on the role of cytokines in diseases of the eye, the Company’s understanding of the structural biology of cytokines and the Company’s ability to rationally design and engineer proteins to modulate the effects of cytokines. Cytokines are cell signaling molecules found in the body that can have



important inflammatory effects. For more information please refer to the Company's website www.elevenbio.com.
Important Information
The Company plans to file with the Securities and Exchange Commission (“SEC”) and mail to its stockholders a proxy statement in connection with the transactions contemplated by the license agreement. Additionally, the Company will file other relevant materials with the SEC in connection with the transactions contemplated by the license agreement. The proxy statement will contain important information about the Company, the transactions contemplated by the license agreement and related matters. Investors and security holders are urged to read the proxy statement carefully when it is available before making any voting or investment decision with respect to the proposed transactions because they will contain important information about the proposed transactions.
Investors and security holders will be able to obtain free copies of the proxy statement and other documents filed with the SEC by the Company through the web site maintained by the SEC at www.sec.gov. In addition, investors and security holders will be able to obtain free copies of the proxy statement from public company by contacting Leah Monteiro at (617) 714-0619.
The Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the transactions contemplated by the license agreement. Information regarding the Company’s directors and executive officers is contained in the Company’s Form 10-K for the fiscal year ended December 31, 2015, and its proxy statement dated April 29, 2016, each of which has been filed with the SEC. Additional information regarding the participants in the solicitation of proxies in respect of the transactions contemplated by the license agreement and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC when they become available.
Cautionary Note on Forward-Looking Statements
Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the potential effectiveness of the license agreement or receipt of payments thereunder, the future rights and obligations of the parties under the license agreement, the Company's strategy, future operations, advancement or maturation of its product candidates and product pipeline, clinical development of the Company's product candidates, including expectations regarding timing of regulatory submissions and initiation of clinical trials, regulatory requirements for initiation of clinical trials and registration of product candidates, the review of its strategic alternatives and the outcome of such review, the completion and results of potential strategic transactions, the sufficiency of its cash resources and other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the occurrence of any event, change or other circumstances that could give rise to the termination of the license agreement, the outcome of any legal proceedings that could be instituted against the Company or its directors related to the license agreement, the inability to consummate the



transactions contemplated by the license agreement due to the failure to obtain the requisite approval of the Company’s stockholders, the uncertainties inherent in the initiation and conduct of clinical trials, availability and timing of data from clinical trials, whether results of early clinical trials or preclinical studies will be indicative of the results of future trials, the adequacy of any clinical models, uncertainties associated with regulatory review of clinical trials and applications for marketing approvals and other factors discussed in the "Risk Factors" section of the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission and other reports on file with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.

Contact:
Leah Monteiro
Eleven Biotherapeutics
617-714-0619


GRAPHIC 3 ebiologoa05.jpg begin 644 ebiologoa05.jpg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end